Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.74+0.01 (+0.07%)
Close on Nov 13, 2026Market cap $12.30BP/E 26.9Yield 0.58%
Dr Reddys Laboratories EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Dr Reddys Laboratories's EV/EBITDA was 17.2× on Nov 11, 2026, against 12.2× a year earlier. Over the last 5 years it ranged from 11.4× to 22.2×, with a median of 14.0×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.2× | +5.0 |
| 2025 | Dec 31, 2025 | 12.2× | −1.5 |
| 2024 | Dec 31, 2024 | 13.7× | −0.1 |
| 2023 | Dec 29, 2023 | 13.9× | −3.8 |
| 2022 | Dec 30, 2022 | 17.6× | −4.5 |
| 2021 | Dec 31, 2021 | 22.2× | −8.9 |
| 2020 | Dec 31, 2020 | 31.0× | +15.4 |
| 2019 | Dec 31, 2019 | 15.6× | −4.8 |
| 2018 | Dec 31, 2018 | 20.4× | +2.1 |
| 2017 | Dec 29, 2017 | 18.3× | +5.2 |
| 2016 | Dec 30, 2016 | 13.1× | – |
See a number that looks wrong?